Korea Investment CORP Boosts Stock Holdings in STERIS plc (NYSE:STE)

Korea Investment CORP increased its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 158.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,830 shares of the medical equipment provider's stock after acquiring an additional 42,800 shares during the period. Korea Investment CORP owned approximately 0.07% of STERIS worth $14,354,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of STE. Avalon Trust Co purchased a new stake in shares of STERIS during the 4th quarter worth approximately $30,000. Human Investing LLC acquired a new stake in STERIS in the fourth quarter valued at $31,000. Anfield Capital Management LLC increased its position in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division raised its stake in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after buying an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its position in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after buying an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

STERIS Trading Down 3.7 %

NYSE:STE traded down $8.25 on Friday, reaching $213.16. The stock had a trading volume of 1,201,030 shares, compared to its average volume of 532,777. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The company has a market cap of $20.94 billion, a price-to-earnings ratio of 45.26 and a beta of 0.92. The firm's fifty day moving average is $223.23 and its two-hundred day moving average is $220.72. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.07%. STERIS's payout ratio is currently 48.41%.

Analyst Ratings Changes

Several equities analysts have weighed in on STE shares. JMP Securities restated a "market outperform" rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Piper Sandler increased their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Finally, Stephens restated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, STERIS presently has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.